TFA salt or acetate salt: what the counter-ion changes about the vial

Where trifluoroacetate comes from, why it stays bound to basic residues, how much of a vial's mass it can be, what the literature reports about it in cell work, and what a certificate should say about salt form.

By Touchstone PeptidesSeptember 22, 20267 minute read

Most synthetic peptides leave the factory as trifluoroacetate salts because trifluoroacetic acid (TFA) is used to cut the peptide from its resin and again as the ion-pairing additive in reversed-phase HPLC. The trifluoroacetate anion pairs with every protonated basic group, so it rides through lyophilization into the vial and can be a meaningful fraction of the powder's mass. Acetate and hydrochloride salts are made by exchanging that anion afterwards. The salt form changes the mass arithmetic, the cake, the pH of a solution and some reported cell-based readouts, so a good certificate names it.

Where trifluoroacetate comes from

Solid-phase synthesis ends with a cleavage step in which TFA removes the finished chain from its resin and strips most protecting groups; AAPPTec's purification guide describes washing the crude product repeatedly "until the odor of TFA is not detectable." The peptide then goes to reversed-phase HPLC, where, in the same guide's words, "the HPLC solvents should contain 0.1 % trifluoroacetic acid (TFA) which acts as an ion-pairing reagent" and sharpens the peptide peaks. AmbioPharm summarises the outcome: the TFA salt "is typically formed due to exposure to a TFA/H2O buffer system in reverse phase high-performance liquid chromatography (HPLC) purification."

When the purified fractions are freeze-dried, water and acetonitrile leave and the trifluoroacetate anions stay, one for each positive charge on the peptide. Roux and colleagues, writing in the Journal of Peptide Science, put it this way: peptides "are mainly obtained in the presence of trifluoroacetic acid (TFA) and, for cationic peptides, as trifluoroacetate (TF-acetate) salts." Solid-phase synthesis and the price walks through the synthesis itself.

Why it stays bound

Trifluoroacetate is the conjugate base of a strong acid (Roux gives the pKa as approximately 0, against 4.5 for acetic acid and about −7 for HCl). It pairs with the protonated sites on a peptide: LifeTein's technical note states that "TFA binds tightly to free amino termini and side chains of cationic residues (e.g., Arg, Lys, His)." A peptide with several lysines and arginines therefore carries several trifluoroacetates, and Roux describes the ion as "tightly bound" enough that removing it is a deliberate manufacturing operation rather than a wash.

That operation has a classic form and several modern ones. The classic route, in Roux's account, "has consisted of freeze-drying the peptide several times in the presence of an excess of a stronger acid than TFA," generally HCl, with the drawback that "working at pH < 1 can induce peptide degradation." The alternatives the same group evaluated on the octapeptide lanreotide were reversed-phase HPLC with an acetate-containing mobile phase, an ion-exchange resin in the acetate form, and a deprotonation and reprotonation sequence in base; the first two gave "partial to almost complete exchange" and the third "complete removal." These are steps a manufacturer performs before a lot is released, and they change what is in the vial. Salt form is one of the specifications a laboratory states when ordering, alongside purity grade and modifications (purity grades, salt exchange and modifications).

How much of the mass it can be

Bachem's care note is explicit: "While peptides for research use are typically > 95% pure by HPLC, the peptide content of the solid may range from 70 to 90% as peptides contain counter ions (e.g. acetate, trifluoroacetate) and residual moisture." Purity is the fraction of the peptidic material that is the right sequence; content is the fraction of the powder that is peptide at all. Net peptide content explains the distinction in full.

GenScript publishes the arithmetic. Its assay-failure note estimates net peptide content as the molecular weight of the target peptide divided by the molecular weight plus the number of TFA counter-ions multiplied by 114, where 114 is the formula mass of TFA (PubChem gives 114.02 for C2HF3O2; acetic acid is 60.05). Applying that formula to two catalog sequences shows why the salt form is not a detail:

Peptide	Sequence	Protonatable basic sites	Peptide share of a fully TFA-paired salt	Peptide share of the acetate salt
Selank	TKPRPGP, MW 751.9	3 (N-terminus, Lys, Arg)	about 69%	about 81%
BPC-157	GEPPPGKPADDAGLV, MW 1419.5	2 (N-terminus, Lys)	about 86%	about 92%

These figures are a stoichiometric ceiling, not a measurement: they assume every basic site carries one anion and ignore water, which Bachem's 70 to 90% range includes. Short, arginine- and lysine-rich peptides sit at the heavy end. The only way to know a lot's true content is to measure it, by amino-acid analysis, nitrogen determination or a quantitative assay against a reference standard, and to report the counter-ion separately.

What the literature reports about TFA in cell-based work

The reason laboratories pay for salt exchange is a 1999 paper by Cornish and colleagues in the American Journal of Physiology. They found that TFA at 10⁻⁸ to 10⁻⁷ M "reduced cell numbers and thymidine incorporation into fetal rat osteoblast cultures after 24 h," with "similar effects ... in cultures of articular chondrocytes and neonatal mouse calvariae," and that when the TFA and hydrochloride salts of amylin, an amylin fragment and calcitonin were compared, "cell proliferation was consistently less with the TFA salts." Their conclusion was methodological: the effect "is likely to be relevant to all studies of purified peptides in concentrations above 10⁻⁹ M in whatever cell or tissue type," and such peptides "should be converted to a hydrochloride or biologically equivalent salt" before their activity is assessed.

GenScript notes that residual TFA "has been found to be an unintended allosteric modulator of the glycine receptor," and that TFA "can reduce the pH of a peptide preparation, and thus may alter the pH of subsequent assays." Roux's group points out that trifluoroacetate "interferes with physicochemical characterizations using infrared spectroscopy," because its carbonyl stretch lands in the amide region. And Zapadka's review of peptide aggregation records that changing the anion altered the aggregation kinetics of the amylin peptide IAPP by factors of four, so the counter-ion can change how fast a peptide self-associates in solution.

All of this concerns a flask or a culture dish. It is why a laboratory chooses a salt form, and it is the whole of what this article claims.

Acetate and hydrochloride

Acetate is the salt form of many approved peptide products; the labels for desmopressin, nafarelin, sermorelin and tesamorelin all read "acetate." AmbioPharm explains the manufacturing preference:

Acetate salts are usually the most common counterion choice and preferred in later development over HCl and TFA salts. They are also chosen because they usually result in a better lyophilizate cake, in contrast to some difficult to handle, "fluffy" peptides that may result from TFA salts.AmbioPharm, Which salt form should I choose for my peptide?

The acetate anion is also lighter than trifluoroacetate (60 against 114 per site), which is why the table above shows a higher peptide share for the same molecule.

Hydrochloride exchange is more complete for strongly basic peptides, according to LifeTein, at the cost of the low-pH exposure Roux describes. Acetate and formate are the milder options. Whichever is chosen, the exchange is followed by another lyophilization, and its success is verified analytically: ion chromatography can quantify residual trifluoroacetate at trace levels (Kaiser and Rohrer reported detection limits below 90 ng/mL in a commercial peptide preparation), and ¹⁹F NMR sees the fluorine directly.

What a certificate should say about the salt form

A certificate that takes the counter-ion seriously carries four lines. The salt form itself (trifluoroacetate, acetate or hydrochloride). The measured counter-ion content, by ion chromatography or fluorine NMR. The net peptide content, by amino-acid analysis or nitrogen. And the water content. Together they turn "5 mg" on a label into a number of micromoles of peptide, which is the figure a laboratory actually needs. How to read a certificate of analysis shows where each line sits on the document. A 99% purity line with no content line is half a certificate.

Sources

For laboratory research use only. Not a drug, not a supplement, and nothing here is a claim about what any of this material does in a person or an animal.

Two things before you come in.